Lumigo 120mg Injection
Prescription Required
Product introduction
Lumigo 120mg Injection is an antiparasitic medication. It is used in the treatment of malaria. It is not used to prevent malaria or to treat severe malaria (where it has affected the brain, lungs, or kidneys).
Lumigo 120mg Injection is used to treat malaria and to help prevent from catching malaria
Lumigo 120mg Injection is used to treat malaria and to help prevent from catching malaria
Uses of Lumigo Injection
Benefits of Lumigo Injection
In Malaria
Lumigo 120mg Injection is an antimalarial medicine and is used alone or with other medications to treat malaria (a serious or life-threatening illness that is spread by a parasite that enters the human body by the bite of infected mosquitoes). This medicine is given by a doctor or nurse and should not be self-administered. Refrain from taking any other medicines or antacids along with this medicine (unless advised by the doctor) as they may affect the absorption of this medicine. Do not use this medicine for treating any other condition without consulting your doctor.
Side effects of Lumigo Injection
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Lumigo
- Headache
- Dizziness
- Weakness
- Loss of appetite
- Injection site reactions (pain, swelling, redness)
How to use Lumigo Injection
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Lumigo 120mg Injection. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Lumigo 120mg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
SAFE IF PRESCRIBED
Lumigo 120mg Injection is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Driving
UNSAFE
Lumigo 120mg Injection may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Kidney
CONSULT YOUR DOCTOR
There is limited information available on the use of Lumigo 120mg Injection in patients with kidney disease. Please consult your doctor.
Liver
CONSULT YOUR DOCTOR
There is limited information available on the use of Lumigo 120mg Injection in patients with liver disease. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Lumigo 120mg Injection
₹396.0/Injection
Falcigo 120mg Injection
Zydus Cadila
₹435.64/injection
10% costlier
Larinate 120mg Injection
Ipca Laboratories Ltd
₹424/injection
7% costlier
Falcinil Forte 120mg Injection
Zuventus Healthcare Ltd
₹427.59/injection
8% costlier
Combither AT 120mg Injection
Aristo Pharmaceuticals Pvt Ltd
₹386.27/injection
2% cheaper
Rtsunate 120mg Injection
Themis Medicare Ltd
₹427.59/injection
8% costlier
Quick tips
- Lumigo 120mg Injection is used in the treatment of malaria.
- Inform your doctor if you are allergic to Lumigo 120mg Injection.
- Do not start or continue Lumigo 120mg Injection and consult your doctor if you are in the first 3 months of pregnancy or if you are breastfeeding.
- Do not drive or operate machinery after taking it because you may feel sleepy.
- Inform your doctor if you notice flu-like symptoms such as chills, fever, muscle pains and any changes in a heartbeat.
- You may be asked for a regular blood test once a week while taking this medicine.
Fact Box
Chemical Class
Sesquiterpene lactones
Habit Forming
No
Therapeutic Class
ANTI MALARIALS
Action Class
Antimalarial- Artemisinin and derivatives
Patient concerns
FAQs
Who should not use Lumigo 120mg Injection?
Use of Lumigo 120mg Injection should be avoided in patients who are allergic to Lumigo 120mg Injection or any of its components. However, if you are not aware of any allergy or if you are using Lumigo 120mg Injection for the first time, consult your doctor.
What should I tell my doctor before starting treatment with Lumigo 120mg Injection?
Before starting treatment with Lumigo 120mg Injection, inform your doctor if you have any other health conditions like a kidney- or heart-related problem. This is because certain medical conditions may affect your treatment and you may even need dose modifications. Also, let your doctor know about all the other medicines you are taking because they may affect, or be affected by, this medicine. Inform your doctor if you are pregnant or breastfeeding.
Is Lumigo 120mg Injection safe?
Lumigo 120mg Injection is safe if used in the dose and duration advised by your doctor. Follow your doctor's instructions carefully and let your doctor know if any of the side effects bother you.
How is Lumigo 120mg Injection administered?
Lumigo 120mg Injection should be administered under the supervision of a trained healthcare professional or a doctor only and should not be self-administered. The dose will depend on the condition you are being treated for and will be decided by your doctor. Follow your doctor’s instructions carefully to get the maximum benefit from Lumigo 120mg Injection.
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Rosenthal PJ. Antiprotozoal Drugs. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 911.
- Medscape.Artesunate. [Accessed 01 Apr. 2019] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 01 Apr. 2019] (online) Available from:
Marketer details
Name: Brochem Health Care Pvt Ltd
Address: Sector-18, Vashi, Navi Mumbai Maharashtra (India) Pin-400705
Country of origin: India
Lab tests offered by us
Related/Popular tests
MRP
₹396
Inclusive of all taxes
1.0 Injection in 1 vial
SOLD OUT